Publications

The rare-to-common disease journey: a winding road to new therapies

 86
The rare-to-common disease journey: a winding road to new therapies

Tags:

Previous Article

How Pseudomonas aeruginosa evade antibiotic therapy?

Next Article

Connecting rare-to-common disease to therapies

Related Posts

Structural pharmacology and mechanisms of GLP-1R signaling

Structural pharmacology and mechanisms of GLP-1R signaling

 121

Cd99l2 regulates excitatory synapse development and restrains immediate-early gene activation

Cd99l2 regulates excitatory synapse development and res...

 63

Roseburia intestinalis-derived butyrate alleviates neuropathic pain

Roseburia intestinalis-derived butyrate alleviates neur...

 140